• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

长期和短期接受治疗的潜伏期儿童的哌醋甲酯血浆浓度

Methylphenidate plasma concentrations in chronically and acutely treated latency-age children.

作者信息

Martin C A, Vore M, Potts B D, Kryscio R J, Norton J C, Madigan J M, Welsh R J, Heffron W M, Liu J P

机构信息

University of Kentucky, Lexington.

出版信息

Pharmacology. 1989;39(1):46-9. doi: 10.1159/000138570.

DOI:10.1159/000138570
PMID:2587616
Abstract

In 5 latency-age boys, methylphenidate plasma concentrations following multiple doses of methylphenidate were consistently higher than those obtained after a single dose. Pharmacological and clinical implications are discussed.

摘要

在5名处于潜伏期年龄的男孩中，多次服用哌甲酯后的血浆浓度始终高于单次服用后的浓度。本文讨论了其药理学和临床意义。

相似文献

1
Methylphenidate plasma concentrations in chronically and acutely treated latency-age children.长期和短期接受治疗的潜伏期儿童的哌醋甲酯血浆浓度
Pharmacology. 1989;39(1):46-9. doi: 10.1159/000138570.
2
Methylphenidate oral dose plasma concentrations and behavioral response in children.儿童中哌醋甲酯口服剂量的血浆浓度及行为反应
Psychopharmacology (Berl). 1982;76(4):329-32. doi: 10.1007/BF00449120.
3
Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.注意缺陷多动障碍儿童和青少年中单剂量和多剂量哌醋甲酯透皮系统或渗透型口服溶液给药的药代动力学。
J Clin Psychopharmacol. 2010 Oct;30(5):554-64. doi: 10.1097/JCP.0b013e3181f0c2f6.
4
Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation.接受高剂量渗透泵控释口服系统制剂治疗的青少年的血浆哌醋甲酯浓度。
J Child Adolesc Psychopharmacol. 2010 Feb;20(1):49-54. doi: 10.1089/cap.2008.0128.
5
Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate.
Pediatrics. 1982 Jun;69(6):688-94.
6
Single-dose pharmacokinetics of NWP06, an extended-release methylphenidate suspension, in children and adolescents with ADHD.NWP06（一种缓释哌甲酯混悬液）在 ADHD 儿童和青少年中的单次剂量药代动力学。
Postgrad Med. 2011 Sep;123(5):80-8. doi: 10.3810/pgm.2011.09.2462.
7
Methylphenidate in hyperactive boys with comorbid tic disorder. I. Clinic evaluations.患有共病抽动障碍的多动男孩服用哌甲酯。I. 临床评估。
Adv Neurol. 1992;58:271-81.
8
Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.注意缺陷障碍儿童的注意力成分、哌甲酯剂量与血药浓度
Pediatrics. 1986 Feb;77(2):222-8.
9
Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.多层层释哌甲酯与速释哌甲酯在注意缺陷多动障碍儿童中的单剂量药代动力学
J Clin Pharmacol. 2007 Jun;47(6):760-6. doi: 10.1177/0091270007299759. Epub 2007 Mar 29.
10
Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.在一项针对注意力缺陷/多动障碍儿童的双盲、安慰剂对照、交叉实验室学校研究中，单次服用盐酸d-苏式-甲基苯丙胺和盐酸d,l-苏式-甲基苯丙胺后，盐酸d-苏式-甲基苯丙胺的比较药效学和血浆浓度。
J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1422-9. doi: 10.1097/01.chi.0000140455.96946.2b.

引用本文的文献

1
Risks and benefits of drugs used in the management of the hyperactive child.用于治疗多动儿童的药物的风险与益处。
Drug Saf. 1993 Jul;9(1):38-50. doi: 10.2165/00002018-199309010-00004.